Advancements in the field of intravaginal siRNA delivery.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Controlled Release

• Publication date

  2013-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jconrel.2012.12.023PMID 23298612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.

  2013cited by this paper
• Overview of microbicides for the prevention of human immunodeficiency virus.

  2012cited by this paper
• Peptides for cell-selective drug delivery.

  2012cited by this paper
• Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection.

  2012cited by this paper
• Vaginal mucoadhesive drug delivery systems

  2012cited by this paper
• The structural biology of HIV-1: mechanistic and therapeutic insights

  2012cited by this paper
• Functionalization with C-terminal cysteine enhances transfection efficiency of cell-penetrating peptides through dimer formation.

  2012cited by this paper
• Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.

  2011cited by this paper
• Simultaneous Delivery of Tenofovir and Acyclovir via an Intravaginal Ring

  2011cited by this paper
• Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.

  2011cited by this paper
• Effects of siRNA-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism

  2011cited by this paper
• Peptide-glycosaminoglycan cluster formation involving cell penetrating peptides.

  2011cited by this paper
• Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements

  2011cited by this paper
• Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system.

  2011influential reference
• Cell-penetrating conjugates of coproporphyrins with oligoarginine peptides: rational design and application for sensing intracellular O2.

  2011cited by this paper
• Cell penetrating peptides for tumor targeting.

  2011cited by this paper
• Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.

  2011cited by this paper
• pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.

  2011cited by this paper
• Plant RNA silencing in viral defence.

  2011cited by this paper
• RNA-based Gene Therapy for the Treatment and Prevention of HIV: From Bench to Bedside

  2011cited by this paper
• STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo.

  2011cited by this paper
• Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?

  2011cited by this paper
• Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.

  2011cited by this paper
• Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid)

  2011influential reference
• High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.

  2011cited by this paper
• Current progress of siRNA/shRNA therapeutics in clinical trials

  2011cited by this paper
• RNA Interference and Cancer Therapy

  2011cited by this paper
• Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives.

  2010cited by this paper
• The impact of carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA delivery

  2010cited by this paper
• RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice.

  2010cited by this paper
• Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity

  2010cited by this paper
• Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.

  2010cited by this paper
• Induction of therapeutic gene silencing in leukocyte-implicated diseases by targeted and stabilized nanoparticles: a mini-review.

  2010cited by this paper
• Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses

  2009cited by this paper
• Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents.

  2009cited by this paper
• Drug delivery: Old polymer learns new tracts.

  2009cited by this paper
• Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.

  2009cited by this paper
• Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier

  2009cited by this paper
• Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2-/-γc-/-) mouse model

  2009cited by this paper
• Strategies to prolong the intravaginal residence time of drug delivery systems.

  2009cited by this paper
• Towards a durable RNAi gene therapy for HIV-AIDS

  2009cited by this paper
• Polymeric nanoparticles for siRNA delivery and gene silencing.

  2009cited by this paper
• Barrier properties of mucus.

  2009cited by this paper
• Durable protection from Herpes Simplex Virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene.

  2009influential reference
• Knocking down barriers: advances in siRNA delivery

  2009cited by this paper
• HIV/AIDS research. Beyond Thailand: making sense of a qualified AIDS vaccine "success".

  2009cited by this paper
• Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA

  2009influential reference
• Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses.

  2009cited by this paper
• Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.

  2009cited by this paper
• Specific Transduction of HIV-Susceptible Cells for CCR5 Knockdown and Resistance to HIV Infection: A Novel Method for Targeted Gene Therapy and Intracellular Immunization

  2009cited by this paper
• State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.

  2008cited by this paper
• Delivery Vehicles for Small Interfering RNA In Vivo

  2008cited by this paper
• T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice

  2008cited by this paper
• Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA

  2008cited by this paper
• Polymeric nanocarriers for siRNA delivery: Challenges and future prospects

  2008cited by this paper
• Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity.

  2008cited by this paper
• Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine.

  2008cited by this paper
• The art and design of genetic screens: RNA interference

  2008cited by this paper
• Silencing of HPV 18 Oncoproteins With RNA Interference Causes Growth Inhibition of Cervical Cancer Cells

  2007cited by this paper
• Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates

  2007cited by this paper
• The development and future of oligonucleotide-based therapies for cervical cancer.

  2007cited by this paper
• Inhibition of herpes simplex virus type 1 by small interfering RNA

  2007cited by this paper
• Optimal design and validation of antiviral siRNA for targeting HIV-1

  2007cited by this paper
• Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes.

  2007cited by this paper
• Apoptosis Induced by Polyethylenimine/DNA Complex in Polymer Mediated Gene Delivery

  2007cited by this paper
• Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.

  2007cited by this paper
• Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives

  2007cited by this paper
• Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

  2007cited by this paper
• Cytotoxicity of polyethyleneimine (PEI), precursor base layer of polyelectrolyte multilayer films.

  2007cited by this paper
• Intravenous Delivery of Anti-RhoA Small Interfering RNA Loaded in Nanoparticles of Chitosan in Mice: Safety and Efficacy in Xenografted Aggressive Breast Cancer

  2006cited by this paper
• Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer*

  2006cited by this paper
• Replication-defective viruses as vaccines and vaccine vectors.

  2006cited by this paper
• Engineering mucosal RNA interference in vivo.

  2006cited by this paper
• An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection

  2006influential reference
• Harnessing in vivo siRNA delivery for drug discovery and therapeutic development

  2006cited by this paper
• Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.

  2006cited by this paper
• Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin

  2006cited by this paper
• Dicer-2 and R2D2 coordinately bind siRNA to promote assembly of the siRISC complexes.

  2006cited by this paper
• Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo.

  2006cited by this paper
• Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery.

  2006cited by this paper
• Intravenous delivery of anti-RhoA siRNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted breast cancer.

  2006cited by this paper
• Chemical modification of siRNAs to improve serum stability without loss of efficacy.

  2006cited by this paper
• Ultrastructure of the human periovulatory cervical mucus.

  2005cited by this paper
• Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol

  2005cited by this paper
• Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes.

  2005cited by this paper
• A review of the physical and chemical properties of human semen and the formulation of a semen simulant.

  2005cited by this paper
• Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo

  2005cited by this paper
• The vagina as a route for systemic drug delivery.

  2005cited by this paper
• RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells

  2005cited by this paper
• Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.

  2005cited by this paper
• RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo

  2005cited by this paper
• Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

  2005cited by this paper
• Stable inhibition of hepatitis B virus expression and replication by expressed siRNA.

  2005cited by this paper
• Inhibition of respiratory viruses by nasally administered siRNA

  2005cited by this paper
• Argonaute2 Is the Catalytic Engine of Mammalian RNAi

  2004cited by this paper
• Nanoscale technology of mucoadhesive interactions.

  2004cited by this paper
• Effect of vector-expressed siRNA on HBV replication in hepatoblastoma cells.

  2004cited by this paper
• The Innate Immune Response to Adenovirus Vectors

  2004cited by this paper
• Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles.

  2004cited by this paper
• Gravity-induced coating flows of vaginal gel formulations: in vitro experimental analysis.

  2004cited by this paper

• Nanotechnology for reproductive healthcare: a comprehensive review.

  2026cites this paper
• Next-generation composite vesicular systems: an in-depth review of proniosomes in advanced drug delivery

  2026cites this paper
• Emerging trends in polymeric mucoadhesive nanocarriers: a promising option for intravaginal HIV preexposure prophylaxis

  2025influential citation
• Vagina, a promising route for drug delivery

  2024cites this paper
• Exploring the potential of nanomedicine for gene therapy across the physicochemical and cellular barriers

  2024cites this paper
• A review on the nanotechnology-based approaches for managing sexually transmitted infections

  2024cites this paper
• The utilization of nanotechnology in the female reproductive system and related disorders

  2024cites this paper
• Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA

  2021cites this paper
• Production and Characterization of Anti-CCR5 siRNA-Loaded Polycaprolactone Nanoparticles for Topical Pre-exposure Prophylaxis.

  2021cites this paper
• Chitosan Oleate Coated PLGA Nanoparticles as siRNA Drug Delivery System

  2021cites this paper
• Biological Aspects and Clinical Applications of Nanoparticles on Treatment and Prophylaxis of HIV

  2020cites this paper
• Anti-α4β7 monoclonal antibody–conjugated nanoparticles block integrin α4β7 on intravaginal T cells in rhesus macaques

  2020cites this paper
• HER-2/neu and MYC gene silencing in breast cancer: therapeutic potential and advancement in nonviral nanocarrier systems.

  2020cites this paper
• Mucus-penetrating PEGylated polysuccinimide-based nanocarrier for intravaginal delivery of siRNA battling sexually transmitted infections.

  2020cites this paper
• A thermosensitive gel based on w1/o/w2 multiple microemulsions for the vaginal delivery of small nucleic acid

  2019cites this paper
• Autophagy induction and PDGFR-β knockdown by siRNA-encapsulated nanoparticles reduce chlamydia trachomatis infection

  2019cites this paper
• Redox-responsive polymer inhibits macrophages uptake for effective intracellular gene delivery and enhanced cancer therapy.

  2019cites this paper
• Design and development of pH-responsive polyurethane membranes for intravaginal release of nanomedicines.

  2018cites this paper
• Microneedle-mediated Vaccine Delivery

  2018cites this paper
• pH-responsive biomaterials for smart intravaginal drug delivery

  2018cites this paper
• Switchable On-Demand Release of a Nanocarrier from a Segmented Reservoir Type Intravaginal Ring Filled with a pH-Responsive Supramolecular Polyurethane Hydrogel.

  2018cites this paper
• Drug Delivery: Localized and Systemic Therapeutic Strategies with Polymer Systems

  2018cites this paper
• RNA interference-based technology: what role in animal agriculture?

  2017cites this paper
• High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA

  2017cites this paper
• RNAi silencing targeting LMP 2 A enhances the radiosensitivity of nasopharyngeal carcinoma cell line C 666-1

  2017cites this paper
• Proniosomes derived niosomes: recent advancements in drug delivery and targeting

  2017cites this paper
• CKIP-1 silencing promotes new bone formation in rat mandibular distraction osteogenesis.

  2017cites this paper
• Nanoformulations for Vaginal Therapy

  2017cites this paper
• Antibody engineering for HIV therapeutics : from fusion inhibition to delivery of genetic regulators

  2017cites this paper
• Nanotechnologies for early diagnosis, in situ disease monitoring, and prevention

  2017cites this paper
• Freeze-dried cylinders carrying chitosan nanoparticles for vaginal peptide delivery.

  2017cites this paper
• Promoting Vaginal Distribution of E7 and MCL-1 siRNA-Silencing Nanoparticles for Cervical Cancer Treatment.

  2017cites this paper
• Nanomedicine in the development of anti-HIV microbicides.

  2016cites this paper
• Uptake Mechanism and Direct Translocation of a New CPP for siRNA Delivery.

  2016cites this paper
• Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA.

  2016cites this paper
• Non-viral gene therapy: Gains and challenges of non-invasive administration methods.

  2016cites this paper
• Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure

  2015cites this paper
• Biodegradable Film for the Targeted Delivery of siRNA-Loaded Nanoparticles to Vaginal Immune Cells.

  2015cites this paper
• Polysaccharide Based Formulations for Mucosal Drug Delivery: A Review.

  2015cites this paper
• Drug Delivery: Intravaginal, Advantages and Challenges

  2015cites this paper
• RNA interference approaches for treatment of HIV-1 infection

  2015cites this paper
• Vaginal gene therapy.

  2015cites this paper
• Polymer-based nanocarriers for vaginal drug delivery.

  2015cites this paper
• Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application.

  2015cites this paper
• Recent advances on anti-HIV vaginal delivery systems development.

  2015cites this paper
• Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions.

  2015cites this paper
• A Reduction and pH Dual‐Sensitive Polymeric Vector for Long‐Circulating and Tumor‐Targeted siRNA Delivery

  2014cites this paper
• Nanoparticle-based drug delivery to the vagina: a review.

  2014cites this paper
• Theranostic nanoparticles for future personalized medicine.

  2014cites this paper
• In vitro evaluation of optimized liposomes for delivery of small interfering RNA

  2014cites this paper
• Development of an Analytical Method for the Rapid Quantitation of Peptides Used in Microbicide Formulations

  2014cites this paper
• Comparative global epidemiology of HIV infections and status of current progress in treatment

  2014cites this paper
• Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs

  2014cites this paper
• Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development

  2014influential citation
• Vaginal Delivery of Biopharmaceuticals

  2014cites this paper
• Intravaginal Gel for the Targeted Delivery of siRNA to T-cells as a Potential Strategy for HIV-1 Prevention

  2014cites this paper
• Interview: Nanomedicine and the fight against HIV/AIDS.

  2014cites this paper
• Delivery Strategies for Developing siRNA-Based Vaginal Microbicides

  2014cites this paper
• A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

  2013cites this paper